NCT05016024 - Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2021

Primary Completion Date

February 15, 2023

Study Completion Date

February 15, 2023

Conditions

Irritable Bowel Syndrome

Interventions

DEVICE

Colilen IBS

Patients will take Colilen IBS in First or Second Period

OTHER

Placebo

Patients will take PlaceboS in First or Second Period

Trial Locations (7)

Istituto Clinico Humanitas, Rozzano

Azienda Ospedaliero Universitaria Pisana, Pisa

Klinische Forschung Karlsruhe GmbH, Karlsruhe

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari

Azienda Ospedaliero Universitaria di Bologna, Bologna

Ospedale SS. Annunziata, Chieti

Policlinico Universitario A. Gemelli, Rome